InvestorsHub Logo

JohnCM

12/09/18 1:28 AM

#717 RE: CornellEngineer #716

I can accept dilution up to a point. Medmen and the future plans of HEXO are too extreem for me. I like Namaste at 90 cents a lot.

JohnCM

12/09/18 6:34 PM

#723 RE: CornellEngineer #716

My investment plan for this week ...

BUY

Alphia under 7.00
Namaste under 1.00
Curaleaf under 5.00
CVSI under 5.00
Origin House under 5.00

JohnCM

12/09/18 6:42 PM

#726 RE: CornellEngineer #716

CITRON: THIS WEED STOCK COULD SURGE 80%

Marijuana stocks APHA, ACB, and CGC are riding sector tailwinds

by Andrea Kramer
cron|ACB|CGC|APHA
Published on Dec 7, 2018 at 1:23 PM

Pot stocks are popping after Altria's CRON stake
U.S. stocks are lower again today, amid lingering concerns about U.S.-China trade and after a tame jobs report. However, one group is bucking the trend: weed stocks. Aphria Inc (NYSE:APHA) is higher on a nod from Citron Research, while fellow pot stocks Aurora Cannabis Inc (NYSE:ACB) and Canopy Growth Corp (NYSE:CGC) are enjoying a halo lift from Cronos Group (CRON), which just scored a big investor in Altria (MO). Here's a closer look at what's moving the shares of APHA, ACB, and CGC.

CITRON SEES 80% UPSIDE FOR APHA

Notable short seller Citron Research today tweeted "Congrats to CRON," after Altria said it took a $1.8 billion stake in the company. Further, the tweet said fellow cannabis concern Aphria "is compelling on all metrics," and predicted a move up to $10 -- a premium of more than 80% to yesterday's close at $5.54.

APHA shares are among the best of the New York Stock Exchange (NYSE) today, up 7.2% to trade at $5.94. Earlier this week, the equity sank to record lows on a scathing report from Hindenburg Research and Quintessential Capital Management, alleging that Aphria's Latin American acquisitions are "virtually worthless." The stock just began trading on the NYSE on Nov. 2, and still remains more than 50% below its Nov. 7 peak of $13.45.

So far today, about 12,000 APHA calls have changed hands -- 10 times the average intraday pace, and roughly double the number of puts exchanged. That's already an all-time high for the freshman weed stock. Digging deeper, however, it appears some speculators are employing calls to bet on a short-term ceiling for the security, selling to open December 7.50 calls.

ACB STOCK RIDES SECTOR TAILWINDS

Aurora Cannabis stock is enjoying sector tailwinds, last seen 8.7% higher at $5.74. The security is on pace to end atop its 10-day moving average for the first time in nearly a month, after yesterday touching its lowest price since ACB first began trading on the Big Board on Oct. 23. The shares are still down 33.5% from their record peak of $8.62 -- tagged on the day of their U.S. debut.

Despite the stock's slide, options traders have remained devotedly bullish. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open nearly 13 ACB calls for every put during the past two weeks. That trend is being echoed today, with around 8,600 calls exchanged so far -- two times the norm -- compared to fewer than 700 puts.

CGC STOCK BOUNCES OFF SUPPORT

Canopy Growth shares -- which have their own high-profile investor in Constellation Brands (STZ) -- are also enjoying a halo lift from CRON, last seen 3.1% higher to trade at $31.27. The stock has spent the past few weeks finding its footing in the $30-$32 region, and while CGC has surrendered about 47% since its Oct. 16 high of $59.25, touched just before Canada legalized recreational marijuana use, the shares have still more than doubled in the past year.

Coming into today, the pot stock was trading near oversold territory, with a 14-day Relative Strength Index (RSI) of 35. Should the equity extend today's bounce, there's plenty of fuel for a short squeeze to drive CGC higher. Short interest jumped 31% in the past two reporting periods, and now sits at a record high, with more than 10% of the stock's float sold short.

JohnCM

12/10/18 3:56 PM

#728 RE: CornellEngineer #716

LIBERTY HEALTH

The Aphria connection

There's no question that Liberty Health Sciences and Aphria have a close connection. At one point, Aphria owned a sizable stake in Liberty before divesting its interest in the company to maintain its listing on the Toronto Stock Exchange (TSX). This move was taken because Liberty has significant operations in the U.S., and the TSX doesn't allow cannabis companies listed on the exchange to have operations in jurisdictions where marijuana is illegal at the federal level.

Aphria CEO Vic Neufeld, though, continues to serve as chairman of the board of directors for Liberty Health Sciences. John Cervini, who co-founded Aphria and is co-chairman of the company's board, is also a director on Liberty's board.

Liberty CEO George Scorsis acknowledged in a phone interview that his company "started off as Aphria's little baby," adding that "unfortunately some of that view still exists." He maintained that Liberty's board acts independently from Aphria.

Scorsis himself previously served as chairman of the board for Scythian Biosciences, now known as SOL Global Investments. Aphria acquired LATAM Holdings from SOL, the transaction that short-sellers alleged was overpriced and helped line the pockets of insiders with Aphria. However, Scorsis stated that he resigned from Scythian's board several months ago, prior to the closing of the LATAM Holdings transaction with Aphria, to focus solely on Liberty Health Sciences.

Behind the Liberty controversy
The initial report about alleged improprieties with Aphria's acquisition of LATAM Holdings didn't refer to Liberty Health Sciences. However, the follow-up report from Hindenburg Research brought Liberty into the Aphria controversy.

Hindenburg Research alleged that Liberty paid 13.5 million in Canadian dollars earlier this year for real estate from a private shell entity controlled by current SOL Global Investments chairman Andy DeFrancesco. The short-seller stated that DeFrancesco's shell company had purchased the Florida property only six days earlier for CA$8.5 million.

The report also insinuated that Aphria allowed Vic Neufeld to buy shares of Liberty Health Sciences "at a 99.5% discount." This was in reference to details surrounding Aphria's backing of Liberty Health Sciences becoming a public entity via a reverse merger in 2017.

Liberty Health Sciences issued a statement on Dec. 6, 2018, that said Hindenburg Research's report contained "a number of factual errors and outdated information." The statement added that Liberty "takes the unconfirmed allegations contained in the report very seriously and will provide updates as they relate to this matter in due course."

Beyond the controversy
It's important to remember that Hindenburg Research profits if Aphria stock falls. The short-seller has a financial interest in spinning anything involving Aphria in the worst light possible. And that includes the connections between Aphria and its executives and Liberty Health Sciences.

Even more important, though, is the fact that none of the allegations reflect negatively on Liberty's long-term prospects. Actually, Liberty announced some encouraging news about its prospects on Friday -- the day after Hindenburg Research's report referencing the company was published.

Liberty reported sales for the quarter ending Nov. 30, 2018, of 3.2 million in Canadian dollars, up 45% from the previous sequential quarter. The company's patient count jumped 46% during the last quarter to around 14,500 patients.

More strong growth appears likely. Liberty opened three new dispensaries in Florida during the last quarter. That brings the company's total number of dispensaries in the state to seven. But Liberty expects to double that number by the end of February 2019, pending approvals from the Florida Department of Health.

The company also provided an update on the construction of its 225,000-square-foot Liberty 360 medical cannabis production facility. Liberty anticipates completing construction in 2019. The company currently uses 20,000 square feet of the property for the cultivation of cannabis and has another 24,000 square feet at its Alachua property. By early 2019, Liberty will add 80,000 square feet as the next phase of construction at Liberty 360 wraps up.

In addition, Liberty said that it expects to open its Dayton, Ohio, medical cannabis dispensary with joint venture partner the Schottenstein Group by the end of March 2019. A 10,000-square-foot processing facility for extraction, refining, formulation, and packaging medical cannabis products is scheduled to open in spring 2019, pending necessary regulatory approvals.

A beaten-down bargain?
The short-seller reports have caused Liberty Health Sciences' share price to sink more than 30% over the last few days. In my view, the sell-off has been overdone -- especially considering that Liberty itself hasn't been accused of any wrongdoing. The good news, though, is that it makes Liberty an attractive bargain for aggressive investors.

Liberty appears to be making steady progress in Florida. Arcview Market Research and BDS Analytics project the state's medical marijuana market will top $1.7 billion by 2022. Liberty Health Sciences thinks it currently claims a 15% market share. With new dispensaries and significantly greater production capacity on the way, the company could boost that share considerably.

Thanks to this past week's negative headlines, Liberty's market cap is only around $230 million. I think that all the company needs to do is stay the course with its efforts in Florida and Ohio to be worth a lot more over the next few years.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.


https://www.fool.com/investing/2018/12/08/aphria-controversy-makes-this-under-the-radar-mari.aspx

JohnCM

12/10/18 6:32 PM

#729 RE: CornellEngineer #716

DOW 23,881

Keep a close eye on that number.

Please, please, can we hold that number?

JohnCM

12/12/18 7:52 PM

#769 RE: CornellEngineer #716

OTC DISCLOSURE & NEWS SERVICE

Sproutly Canada, Inc. Discusses Innovation and Expansion in Exclusive Audio Interview with NetworkNewsWire

NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NetworkNewsAudio - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G), a client of NNW focused on becoming the leading supplier to the cannabis beverage and edibles market.

The interview can be heard at

Audio Interview

NNW’s Stuart Smith introduces Sproutly president and CEO Keith Dolo in an interview that highlights the company’s strategy to pave a leading-edge in the cannabis industry.

Dolo explains Sproutly’s mission to become the leading supplier to the cannabis beverage and edibles market. The company is a Canadian licensed producer that operates a purpose-built facility in Toronto with intent to cultivate high-quality, pharmaceutical-grade cannabis utilizing a revolutionary technology gained through its recent acquisition of Infusion Biosciences.

The move allows Sproutly to combine purpose-built capabilities and premium cannabis to create what Dolo describes as, “the world’s first and only truly water-soluble cannabis solution and bio-natural oils.”

According to Dolo, these will deliver revolutionary brands and top-products to both Canadian and international markets that are distinguished among traditional oils and beverages currently available.

Sproutly’s delivery process allows consumers to control the dosing via a water-soluble cannabis solution. The technology enables the capability of bio-availability and effects within five minutes (rather than the standard 45 to 120 minutes) and output/removal of effects between 60 and 90 minutes (instead of the standard effects lasting anywhere from four to eight hours, or up to one or two days for products currently on the market).

Dolo then discusses Sproutly’s plan to market its products internationally in 2019. The company’s recent venture with Global Canna, the largest tier 3 producer in Jamaica and all of Montego Bay, will enable creation of unique Jamaican-based products from their grow facilities to be distributed throughout the Caribbean.

The company is further pursuing additional distribution agreements, with a focus on Canada, Jamaica, Israel, Australia, and the entire European Union throughout countries that allow shipping, distribution and consumption of regulated cannabis products.

With a leadership team that combines decades of in-depth experience, including expertise growing well-known Fortune 200 and 500 companies and experience in the CBD and beverage space both in North America and internationally, Dolo claims that, “As much as we right now are a cannabis company, if you will tune in in about 30 to 60 days, you’ll see our company graduate to more of a CBD beverage organization.”

For investors looking at Sproutly, Dolo notes, “As the industry determines how to solve the problems with beverages and the quick onset, the quick offset and the formulation capacity, essentially, Sproutly and our Infusion Biosciences [subsidiary] have really already solved the issues that plague the cannabis beverage and edibles industry. We’ve created a number of unique products and formulations with extremely fast onset and fast offset profiles to allow individuals to control the doses.”

This, Dolo explains, combined with the company’s unique business model and its positioning as a licensed producer and technology company create distinct advantages for Sproutly.

About Sproutly Canada, Inc.

Sproutly’s core mission is to become the leading supplier to the cannabis beverage and edibles market. The company’s Toronto based, ACMPR licensed facility was built to cultivate pharmaceutical grade cannabis to supply a technological breakthrough in producing and formulating the first natural, truly water-soluble cannabis solution. The company’s water-soluble ingredients and our bio-natural oils will deliver revolutionary brands to international markets that are clamoring for well-defined commercial products. Sproutly’s business focus is to execute on partnerships with local and globally established consumer brands to leverage their existing customer bases, further expand brand loyalty, assist with marketing, and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide. For more information on Sproutly, visit the company’s website at www.Sproutly.ca.

JohnCM

12/15/18 1:12 PM

#776 RE: CornellEngineer #716

HMLSF looking at the one year chart, I can see why buy and hold can be a terrifying option. Swing trading, rolling or trading around a position would work but how many individual investors are up to the task?

JohnCM

12/17/18 10:27 PM

#779 RE: CornellEngineer #716

Discussion Groups

ACB Aurora Cannabis Inc. 37,345 4 minutes ago Cannabis
Cannabis Investment Club 778 4 minutes ago Industry
USMJ North American Cannabis Holdings Inc. 79,386 55 minutes ago
KNHBF ICC Intl Cannabis Corp. 214 1 hour ago Cannabis
GCAN Greater Cannabis Company Inc. 10,898 1 hour ago Cannabis
SPRWF Supreme Cannabis Co Inc. 27,768 2 hours ago Medical -
SCNA Smart Cannabis Corp. 8,948 3 hours ago Cannabis
LIHTF Liht Cannabis Corp. 2,074 3 hours ago Cannabis
TCNNF Trulieve Cannabis Corp 1,204 4 hours ago Cannabis
HRVOF Harvest One Cannabis, Inc 39 4 hours ago Cannabis
CBDS Cannabis Sativa Inc. 4,553 4 hours ago Cannabis
CBWTF Auxly Cannabis Group Inc. 2,105 5 hours ago Cannabis
FNNZF FinCanna Capital Corp. (FNNZF) / Medical Cannabi 125
CAPTAINSCOTTY''S CANNABIS COALITION 1,834 9 hours ago Support F
Cannabis and Hemp Sector Ideas 231 9 hours ago User's Groups
CBIS Cannabis Science, Inc. 128,481 10 hours ago C
REFG Medical Cannabis Payment Solutions 2,120 11 hours ago
CCAN Canadian Cannabis Corp. 368 12 hours ago Cannabis
IGPK Integrated Cannabis Solutions Inc. 3,062 1 day ago C
Cannabis - Oils and CBD 29 2 days ago Support Forums
NUGS Cannabis Strategic Ventures 11,476 2 days ago Cannabis
TSXV:EMC Emblem Cannabis 601 2 days ago Cannabis
Cannabis Best Opportunity Stocks $0.10 to $0.75 87 3 days ago I
Cannabis U.S. Companies 1,874 3 days ago User's Groups
NCNNF 48North Cannabis Corp. 0 3 days ago Cannabis
VVCIF Vivo Cannabis Inc. 993 3 days ago Cannabis
CNAB United Cannabis Corp. 5,710 3 days ago Cannabis
NACNF National Access Cannabis Corp 27 5 days ago Cannabis
HSTRF BlissCo Cannabis Company 102 5 days ago Cannabis
VRNDF Delta 9 Cannabis Inc. 435 5 days ago Cannabis
CANN General Cannabis Corp. 11,546 5 days ago Cannabis
NRTH 48North Cannabis Company 26 6 days ago Cannabis
AMMJ American Cannabis Company Inc. 13,998 6 days ago Cannabis
HTHHF Cannabis 1 6 days ago Cannabis
CBAQF Cannabis Strategies Acquisition Corp 30 7 days ago C
HERTF Heritage Cannabis Holdings Corp. 133 7 days ago C
FUAPF Global Cannabis Applications Corp. 206 8 days ago C
Cannabis IPO Watch CA and US 210 14 days ago Health and Sc
ICNAF Integrated Cannabis Company Inc. 299 15 days ago M
TSXV:FIRE The Supreme Cannabis Company, Inc. 47 15 days
Cannabis Pharmaceuticals 25 1 month ago User's Groups
PRCNF Pure Global Cannabis Inc. 48 1 month ago Cannabis
Cannabis Stock Plays 503 1 month ago User's Groups
TSXV:ICC International Cannabis Corporation 52 1 month
CNSX:LOAN The Cannabis Merchants Bank: Redfund Cap Corp 25
Cannabis Canadian and U. S. Priced At $0.01 to $0. 644 2 mont
ACB Aurora Cannabis 172 2 months ago Cannabis
TSXV:NAC National Access Cannabis 27 3 months ago
Redfund CAp Corp - The Cannabis Merchants Bank 4 3 months ago
TSXV:XLY Auxly Cannabis 22 3 months ago Cannabis
HUGE CNX Top Cannabis Newcomer! 0 5 months ago 3
SPBBF Speakeasy Cannabis Club Ltd. 19 6 months ago C
TSXV:CBW Cannabis Wheaton Income Corp. 263 6 months ago
CWWBF Cannabis Growth Opportunity Corp 1 6 months ago
Speak SpeakEasy Cannabis 0 7 months ago Cannabis
EASY SpeakEasy Cannabis Club 0 7 months ago Cannabis
CNSX:APP Global Cannabis Applications Corp 8 7 mon
Cannavestor - Cannabis Investments 331 9 months ago I
Cannabis Industry Coin (XCIUSD) 0 10 months ago Coins
CannabisCoin (CANNUSD) 0 10 months ago Coins
TSXV:CBW.WT Cannabis Wheaton Corp 4 12 months ago C
Invest in Cannabis 21 1 year ago Industry Specific
Cannabis Investor Group 3 1 year ago Industry Specific
TSV:ACB Aurora Cannabis Inc. 2 1 year ago Cannabis
TSXV:ICC Icc International Cannabis 1 1 year ago C
South American Coal and Cannabis 2 1 year ago User's G
Bedrocan Cannabis Co. (fka BNRDF) 39 3 years ago Delisted
TSXV:BED Bedrocan Cannabis Corp. 875 3 years ago Medical -
Risks of Cannabis stocks 0 4 years ago Industry Specific
BNRDF BEDROCAN CANNABIS CO 29 4 years ago Cannabis
South Florida Cannabis Traders 5 5 years ago User's Groups
C2J Cannabis Medical Solutions Inc. 4 7 years ago Foreign S

JohnCM

12/17/18 11:28 PM

#780 RE: CornellEngineer #716

If we ( cannabis investors ) want to stay alive, we have to be "stock pickers."

Investing in an exchange traded fund will not cut it.

We have to find the gems that have been beaten down to ridiculous levels.

I wanted to start a discussion board specializing in the best MJ stocks that have been beaten down. The "best opportunities."